Literature DB >> 1976096

GBR 12909 reverses the SCH 23390 inhibition of rewarding effects of brain stimulation.

P P Rompré1, P Bauco.   

Abstract

Curve-shift was used to test the effect of SCH 23390, a dopamine D1 receptor antagonist, and GBR-12909, a selective dopamine uptake blocker, on self-stimulation behavior. GBR 12909 (8 mg/kg) produced a significant decrease in self-stimulation threshold when administered alone, and reversed the increase in threshold produced by SCH 23390 (0.08 mg/kg). The reversal of the SCH 23390 effect by GBR 12909 suggests that the inhibition of self-stimulation produced by SCH 23390 is due to blockade of dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976096     DOI: 10.1016/0014-2999(90)90510-d

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Self-administration of GBR 12909 on a fixed ratio and progressive ratio schedule in rats.

Authors:  D C Roberts
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  Reduction in Ventral Midbrain NMDA Receptors Reveals Two Opposite Modulatory Roles for Glutamate on Reward.

Authors:  Giovanni Hernandez; Ali Khodami-Pour; Daniel Lévesque; Pierre-Paul Rompré
Journal:  Neuropsychopharmacology       Date:  2015-01-12       Impact factor: 7.853

Review 3.  To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making.

Authors:  Giovanni Hernandez; Joseph F Cheer
Journal:  Front Behav Neurosci       Date:  2015-12-17       Impact factor: 3.558

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.